Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?

Intravesical immunotherapy with bacillus Calmette-Guérin (BCG) is the standard of care for high-risk and intermediate-risk non-muscle-invasive bladder cancer (NMIBC). Several BCG strains are available. Despite originating all from subcultures of the same Mycobacterium, strains are genetically differ...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Andrea, David, Gontero, Paolo, Shariat, Shahrokh F., Soria, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414340/
https://www.ncbi.nlm.nih.gov/pubmed/30976572
http://dx.doi.org/10.21037/tau.2018.08.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414340/
https://www.ncbi.nlm.nih.gov/pubmed/30976572
http://dx.doi.org/10.21037/tau.2018.08.19

Ejemplares similares